肿瘤信号传导研究团队

图片3.png负责人:王红阳

教授、教育部长江特聘教授、主任医师、博士生导师、中国工程院院士

 王红阳,女,发展中国家科学院(TWAS,原称第三世界科学院)院士,教育部长江"特聘教授",2005年当选中国工程院院士。现任国家肝癌科学中心主任、国际合作生物信号转导研究中心主任。兼任国家自然科学基金委员会医学科学部主任,“癌基因及相关基因”国家重点实验室名誉主任。长期从事肿瘤的基础与临床研究,对肿瘤的信号网络调控、肝癌新分子标志物鉴定及应用等有重要建树。在Nature Comm.、Cancer Cell、J.E.M.、Gastroenterology(USA)、Hepatology、Cancer Res.、Nature 和Oncogene等有影响的主流期刊发表论文150多篇,总影响因子861;申报国内外专利28项,已获授权11项(国际专利1项)。先后主持国家传染病重大科技专项课题、国家自然科学基金创新研究群体、重点项目、杰出青年基金等多项项目。以第一完成人获国家科学技术创新团队奖(首届)、国家自然科学二等奖(2006)、何梁何利科技进步奖(2004)、上海医学科技一等奖(2003、2008)和上海市科技进步二等奖(2003)等8项。

 
Section of Signal Transduction of Cancer

 Prof. Hongyang Wang

 

Member of Chinese Academy of Engineering

Distinguished professor for Chang Jiang Scholars Program of Ministry of Education

 

Professor Hongyang Wang was selected as a member of Chinese Academy of Engineering In 2005. Prof. Wang is the director of National Center for Liver Cancer Research of China, and director of International Cooperation Laboratory on Signal Transduction in Shanghai Eastern Hepatobiliary Surgery Hospital. She is also the first director of the Health Science Department of the National Natural Science Foundation of China (NSFC). Prof. Wang focuses on molecular mechanisms and translational medicine research of tumors and made an important contribution to molecular mechanism of tumorigenesis, signaling network regulation of tumor, and liver cancer biomarkers finding. Prof. Wang has undertaken National Science Foundations for Distinguished Young Scholars, key projects of National Natural Science Foundations, International cooperation Foundations and other important research projects funded by government. She has published more than 150 papers in the important international magazines such as Nature CommCancer, Cell, J.E.M., Gastroenterology,etc, with a total impact factor of 861. She has applied 28 innovation patents (2 international patents), and 11 of them have been warranted. She has received the prize of National Awards for Science and Technology Progress(Innovation Team Award), National Natural Science Award (Grade II), Science and Technology Award of HO LEUNG HO LEE FOUNDATION, and Shanghai Medical Science and Technology Award (Grade I).